SRF's Q4 profit jumps 25%. Should you hop on?

SRF has just posted a blockbuster fourth quarter. Net profit jumped 25 per cent year-on-year to Rs 526 crore, beating market expectations. Revenues climbed 21 per cent to Rs 4,313 crore. On the face of it, the diversified chemicals major seems to be firing on all cylinders.

But dig a little deeper, and you'll see that not all segments are cruising at the same speed. While chemicals and packaging films are propelling growth, technical textiles, once a key pillar, are losing steam. So, is this just a one-off sprint, or can SRF keep this pace in FY26?

SRF Q4 FY25 snapshot

Segment-wise:

• Specialty chemicals: Led the charge with a 30 per cent revenue spike. SRF saw strong demand from agrochemical and pharma intermediates.
• Fluorochemicals: Benefited from hot summer demand. AC refrigerant sales hit record highs.
• Packaging films: Margin recovery and better capacity utilisation pushed profit up more than 200 per cent.
• Technical textiles: Dragged overall performance. Profit slumped 43 per cent due to cheap imports.
  

Clearly, chemicals are SRF's growth engine. But volatility in crude prices, demand cycles, and environmental regulations could be near-term speed bumps.

What SRF does

SRF isn't your average industrial name. It started as a tyre cord maker in the '70s but now straddles a wide range of businesses—from specialty chemicals and fluorochemicals to packaging films and coated fabrics. Its products go into air conditioners, agri inputs, pharma, even chips.
Today, chemicals contribute the lion's share of profits—and that's where most of the market's optimism lies.

Capex and China+1 play
SRF has lined up a capital expenditure plan of over Rs 2,800 crore—mainly aimed at expanding its fluorochemicals and specialty chemicals capacity. A significant chunk is geared toward export markets, which now contribute close to half of its chemicals revenue.

With global companies looking to diversify away from China (the so-called China+1 trend), SRF is well-positioned to capture incremental global demand in pharma and agro-intermediates.

Valuation check
SRF currently trades at a trailing P/E of around 71x, which is significantly higher than peers like Aarti Industries (~51x). That's a hefty premium, suggesting investors are pricing in strong growth and flawless execution.

At this level, even a small earnings miss or margin squeeze could trigger a sharp market reaction. For value-conscious investors, this valuation demands a high level of conviction.

Management outlook
In its Q4 commentary, SRF's management maintained a cautiously optimistic tone. It expects refrigerants and packaging films to remain strong in FY26, while continuing to invest heavily in chemicals expansion. However, they flagged inflation and global macro risks as variables that could impact margins.

Value Research ratings

Here's how SRF stacks up on Value Research's radar:

• Quality: 6/10
• Growth: 7/10
• Valuation: 3/10
• Momentum: 10/10

Momentum is red-hot. But valuation looks stretched after the recent run-up.

Final word

SRF's Q4 was strong, but not flawless. The chemicals business is clearly the showstopper, and the company's long-term strategy seems well-aligned with rising global demand for specialty chemicals.

But here's the rub: the stock has had a solid run, and a lot of optimism may already be baked into the price. With weak spots like technical textiles and the ever-present risks from global demand swings and regulations, it's worth staying cautious.

If you're a long-term investor who believes in India's chemicals growth story, SRF could deserve a spot on your watchlist. Just don't expect every quarter to sparkle like this one.

Why smart investors trust expert research

Want sharper, stock-focused guidance beyond gold? Value Research Stock Advisor gives you expert-researched stock recommendations, long-term strategies and the discipline to help you build real wealth. Join thousands of successful Indian investors who trust us to guide their equity journey.

Check it out here: Value Research Stock Advisor